Intracoronary glycoprotein IIb/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden:

Related Experiment Video

Updated: May 14, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Gabriel Maluenda1, Byron C Sizemore, George Revtyak

  • 1Washington Hospital Center, Washington, DC 20010, USA.

Cardiovascular Revascularization Medicine : Including Molecular Interventions
|February 5, 2013
PubMed

Insights

The ClearWay™ perfusion catheter effectively reduced thrombus burden and improved coronary flow during percutaneous coronary intervention (PCI). This method using glycoprotein IIb/IIIa inhibitors offers a significant benefit for patients with intracoronary thrombus.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Devices

Background:

  • Intracoronary thrombus during percutaneous coronary intervention (PCI) is linked to adverse patient outcomes.
  • Effective management of thrombus burden is crucial for successful PCI.

Purpose of the Study:

  • To evaluate the ClearWay™ (CW) perfusion catheter's efficacy in reducing thrombus burden.
  • To assess the improvement in coronary blood flow during PCI using the CW catheter.

Main Methods:

  • A multicenter registry study involving 102 patients undergoing PCI with intracoronary thrombus.
  • Data collected via online survey from 15 US sites.
  • Angiographic assessment of thrombus burden and coronary flow (Thrombolysis In Myocardial Infarction [TIMI] flow) after intracoronary infusion of glycoprotein (GP) IIb/IIIa inhibitors via the CW catheter.

Main Results:

  • Intracoronary infusion of GP IIb/IIIa inhibitors via the CW catheter led to a 52% reduction in visible thrombus (p<0.001).
  • Thrombolysis In Myocardial Infarction (TIMI) flow improved significantly, with restoration in 90.2% of lesions.
  • Visible thrombus clearance was achieved in 91.8% of lesions.

Conclusions:

  • Intracoronary infusion of GP IIb/IIIa inhibitors using the ClearWay™ perfusion catheter significantly reduces thrombus burden.
  • The ClearWay™ catheter improves coronary flow in patients with thrombus during PCI.
  • This approach is associated with substantial procedural success in managing intracoronary thrombus.
Abstract

Keywords:
Glycoprotein inhibitorPerfusion catheterThrombus burden

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in G&#246;ttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...